The Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
The Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel.
J Dermatol Sci. 2022 Jul;107(1):41-47. doi: 10.1016/j.jdermsci.2022.05.004. Epub 2022 May 13.
Sclerodermoid graft-versus-host disease (GVHD) is the most severe form of chronic GVHD (cGVHD) and represents a considerable therapeutic challenge. Due to the scarcity of human studies on sclerodermoid cGVHD, the pathogenesis of this entity is not fully understood.
To identify the differential expression of fibrosis-related genes in skin lesions of human lichenoid and sclerodermoid cGVHD and to assess the expression of their corresponding proteins.
PCR array analysis was performed on RNA extracted from three skin biopsies of sclerodermoid cGVHD patients and three normal skin samples, for fibrosis-related gene expression profiles followed by evaluation of their corresponding protein expressions. The expressions of Tissue inhibitor of metalloproteinase 3 (TIMP3), matrix metalloproteinase 1 (MMP1), TIMP1, and TIMP2 were further studied by immunohistochemistry. Demographic, clinical and immunohistochemical parameters of the two cGVHD groups and the control group were compared. The Pearson correlation coefficient was used to assess the correlation between data among the study groups.
We identified 44 upregulated and 14 downregulated genes in the skin samples of sclerodermoid cGVHD compared to the control group. TIMP3 was positive in 13/21 biopsies of cGVHD and in one biopsy of the control group. The average staining intensity was significantly higher in the cGVHD group compared to the control group. TIMP3 was expressed mainly in dermal blood vessels. cGVHD specimens with positive TIMP3 staining had a statistically significantly higher total microvascular area than the negative specimens.
TIMP3 levels are increased in both subtypes of cGVHD and are associated with increased dermal vascularity.
硬皮病样移植物抗宿主病(GVHD)是慢性移植物抗宿主病(cGVHD)中最严重的形式,是一个相当大的治疗挑战。由于人类对硬皮病样 cGVHD 的研究甚少,因此该实体的发病机制尚不完全清楚。
鉴定人类苔藓样和硬皮病样 cGVHD 皮肤病变中与纤维化相关的基因的差异表达,并评估其相应蛋白的表达。
对 3 例硬皮病样 cGVHD 患者和 3 例正常皮肤样本的皮肤活检组织提取的 RNA 进行 PCR 阵列分析,以进行纤维化相关基因表达谱分析,随后评估其相应蛋白的表达。进一步通过免疫组织化学研究组织金属蛋白酶抑制剂 3(TIMP3)、基质金属蛋白酶 1(MMP1)、TIMP1 和 TIMP2 的表达。比较两组 cGVHD 患者和对照组的人口统计学、临床和免疫组化参数。使用 Pearson 相关系数评估研究组之间数据的相关性。
与对照组相比,硬皮病样 cGVHD 皮肤样本中发现有 44 个上调基因和 14 个下调基因。TIMP3 在 21 例 cGVHD 活检中有 13 例阳性,在对照组的 1 例活检中有阳性。与对照组相比,cGVHD 组的平均染色强度显著更高。TIMP3 主要在真皮血管中表达。TIMP3 染色阳性的 cGVHD 标本的总微血管面积明显高于阴性标本。
TIMP3 水平在两种 cGVHD 亚型中均升高,并与真皮血管生成增加有关。